Tumor necrosis factor alpha promotes the expression of immunosuppressive proteins and enhances the cell growth in a human bone marrow-derived stem cell culture

Experimental Cell Research

Volumn 317, Issue 6, 2011, Pages 791-801

  Miettinen, Johanna A ^a   Pietilä, Mika ^a   Salonen, Riikka J ^a   Ohlmeier, Steffen ^a   Ylitalo, Kari ^a   Huikuri, Heikki V ^a   Lehenkari, Petri ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

HLA antigens; Immunosuppression; Inflammation; Intracellular adhesion molecule 1; Mesenchymal stem cells; TNF alpha

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; LEUKOCYTE ANTIGEN; MEMBRANE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; MASS SPECTROMETRY; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 79952195895     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.12.010     Document Type: Article

References (44)

1. Chen Y., Shao J.Z., Xiang L.X., Dong X.J., Zhang G.R. Mesenchymal stem cells: a promising candidate in regenerative medicine. Int. J. Biochem. Cell Biol. 2008, 40:815-820.
2. Wallach D., Boldin M.P., Goltsev Y.V. Tumor necrosis factor receptor and Fas signalling mechanisms. Ann. Rev. Immunol. 1999, 17:331-367.
3. Markel T.A., Crisostomo P.R., Wang M., Herring C.M., Meldrum D.R. Activation of individual tumor necrosis factor receptors differentially affects stem cell growth factor and cytokine production. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 293:G657-G662.
4. Schütze S., Tchikov V., Schneider-Brachert W. Regulation of TNFR1 and CD95 signalling by receptor compartmentalization. Nat. Rev. Mol. Cell Biol. 2008, 9:655-662.
5. Marchetti L., Klein M., Schlett K., Pfizenmaier K., Eisel U.L. TNF mediated neuroprotection against glutamate induced excitotoxicity is enhanced by NMDA receptor activation: essential role of a TNF receptor 2 mediated, PI3 kinase dependent NF-kB pathway. J. Biol. Chem. 2004, 279:32869-32881.
6. Crisostomo P.R., Wang Y., Markel T.A., Wang M., Lahm T., Meldrum D.R. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am. J. Physiol. Cell Physiol. 2008, 294:C675-C682.
7. Ait-Ali D., Turquier V., Tanguy Y., Thouënnon E., Ghzili H., Mounien L., Derambure C., Jégou S., Salier J.P., Vaudry H., Eiden L.E., Anouar Y. Tumor necrosis factor (TNF)-alpha persistently activates nuclear factor-kappaB signaling through the type 2 TNF receptor in chromaffin cells: implications for long-term regulation of neuropeptide gene expression in inflammation. Endocrinology 2008, 149:2840-2852.
8. Böcker W., Docheva D., Prall W.C., Egea V., Pappou E., Rossmann O., Popov C., Mutschler W., Ries C., Schieker M. IKK-2 is required for TNF-alpha-induced invasion and proliferation of human mesenchymal stem cells. J. Mol. Med. 2008, 86:1183-1192.
9. Wang M., Crisostomo P.R., Herring C., Meldrum K.K., Meldrum D.R. Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:R880-R884.
10. Wang M., Zhang W., Crisostomo P., Markel T., Meldrum K.K., Fu X.Y., Meldrum D.R. STAT3 mediates bone marrow mesenchymal stem cell VEGF production. J. Mol. Cell. Cardiol. 2007, 42:1009-1015.
11. Pober J.S., Lapierre L.A., Stolpen A.H., Brock T.A., Springer T.A., Fiers W., Bevilacqua M.P., Mendrick D.L., Gimbrone M.A. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J. Immunol. 1987, 138:3319-3324.
12. Zuber P., Accolla R.S., Carrel S., Diserens A.C., de Tribolet N. Effects of recombinant human tumor necrosis factor-alpha on the surface phenotype and the growth of human malignant glioma cell lines. Int. J. Cancer 1988, 42:780-786.
13. Marley G.M., Doyle L.A., Ordóñez J.V., Sisk A., Hussain A., Yen R.W. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines. Cancer Res. 1989, 49:6232-6236.
14. Sedlák J., Speiser P., Zeillinger R., Krugluger W., Wiltschke C., Kubista E., Chorváth B. Cytokine (IFN-alpha, IFN-gamma, IL-1-alpha, TNF-alpha)-induced modulation of HLA cell surface expression in human breast cancer cell lines. Neoplasma 1992, 39:269-272.
15. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop D.J., Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy 2006, 8:315-317.
16. Annunen-Rasila J., Ohlmeier S., Tuokko H., Veijola J., Majamaa K. Proteome and cytoskeleton responses in osteosarcoma cells with reduced OXPHOS activity. Proteomics 2007, 7:2189-2200.
17. Leskelä H.V., Risteli J., Niskanen S., Koivunen J., Ivaska K.K., Lehenkari P. Osteoblast recruitment from stem cells does not decrease by age at late adulthood. Biochem. Biophys. Res. Commun. 2003, 311:1008-1013.
18. Ojeda M., Silva C.V., Rosaínz M.J.A., Fernández-Ortega C. TNFα production in whole blood cultures from healthy individuals. Biochem. Biophys. Res. Commun. 2002, 292:538-541.
19. Cho H.H., Shin K.K., Kim Y.J., Song J.S., Kim J.M., Bae Y.C., Kim C.D., Jung J.S. NF-kappaB activation stimulates osteogenic differentiation of mesenchymal stem cells derived from human adipose tissue by increasing TAZ expression. J. Cell. Physiol. 2010, 223:168-177.
20. Hess K., Ushmorov A., Fiedler J., Brenner R.E., Wirth T. TNF alpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway. Bone 2009, 45:367-376.
21. Kras K.M., Hausman D.B., Martin R.J. Tumor necrosis factor-alpha stimulates cell proliferation in adipose tissue-derived stromal-vascular cell culture: promotion of adipose tissue expansion by paracrine growth factors. Obes. Res. 2000, 8:186-193.
22. Langen R.C., Schols A.M., Kelders M.C., Wouters E.F., Janssen-Heininger Y.M. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. FASEB J. 2001, 15:1169-1180.
23. Murakami S., Lefebvre V., de Crombrugghe B. Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor alpha. J. Biol. Chem. 2000, 275:3687-3692.
24. Sitcheran R., Cogswell P.C., Baldwin A.S. NF-kappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism. Genes Dev. 2003, 17:2368-2373.
25. Gilbert L., He X., Farmer P., Boden S., Kozlowski M., Rubin J., Nanes M.S. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 2000, 141:3956-3964.
26. Li B., Shi M., Li J., Zhang H., Chen B., Chen L., Gao W., Giuliani N., Zhao R.C. Elevated tumor necrosis factor-alpha suppresses Taz expression and impairs osteogenic potential of Flk-1{thorn} mesenchymal stem cells in patients with multiple myeloma. Stem Cells Dev. 2007, 16:921-930.
27. Kashiwakura Y., Katoh Y., Tamayose K., Konishi H., Takaya N., Yuhara S., Yamada M., Sugimoto K., Daida H. Isolation of bone marrow stromal cell-derived smooth muscle cells by a human SM22alpha promoter: in vitro differentiation of putative smooth muscle progenitor cells of bone marrow. Circulation 2003, 107:2078-2081.
28. Nincheri P., Luciani P., Squecco R., Donati C., Bernacchioni C., Borgognoni L., Luciani G., Benvenuti S., Francini F., Bruni P. Sphingosine 1-phosphate induces differentiation of adipose tissue-derived mesenchymal stem cells towards smooth muscle cells. Cell. Mol. Life Sci. 2009, 66:1741-1754.
29. Assinder S.J., Stanton J.A., Prasad P.D. Transgelin: an actin-binding protein and tumour suppressor. Int. J. Biochem. Cell Biol. 2009, 41:482-486.
30. Majumdar M.K., Keane-Moore M., Buyaner D., Hardy W.B., Moorman M.A., McIntosh K.R., Mosca J.D. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J. Biomed. Sci. 2003, 10:228-241.
31. Ren G., Zhao X., Zhang L., Zhang J., L'Huillier A., Ling W., Roberts A.I., Le A.D., Shi S., Shao C., Shi Y. Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J. Immunol. 2010, 184:2321-2328.
32. Bjorkman P.J., Parham P. Structure, function and diversity of class I major histocompatibility molecules. Annu. Rev. Biochem. 1990, 59:253-288.
33. Tanaka K., Kasahara M. The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28. Immunol. Rev. 1998, 163:161-176.
34. Wong G.H., Elwell J.H., Oberley L.W., Goeddel D.V. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 1989, 58:923-931.
35. Becker M.A., Kim M. Regulation of purine synthesis de novo in human fibroblasts by purine nucleotides and phosphoribosylpyrophosphate. J. Biol. Chem. 1987, 262:14531-14537.
36. Weirich C.S., Erzberger J.P., Barral Y. The septin family of GTPases: architecture and dynamics. Nat. Rev. Mol. Cell Biol. 2008, 9:478-489.
37. Surka M.C., Tsang C.W., Trimble W.S. The mammalian septin MSF localizes with microtubules and is required for completion of cytokinesis. Mol. Biol. Cell 2002, 13:3532-3545.
38. Ohmori Y., Schreiber R.D., Hamilton T.A. Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB. J. Biol. Chem. 1997, 272:14899-14907.
39. Ledebur H.C., Parks T.P. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers. J. Biol. Chem. 1995, 270:933-943.
40. Darnell J.E., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421.
41. Holzinger D., Jorns C., Stertz S., Boisson-Dupuis S., Thimme R., Weidmann M., Casanova J.L., Haller O., Kochs G. Induction of MxA gene expression by influenza A virus requires type I or type III interferon signalling. J. Virol. 2007, 81:7776-7785.
42. Luciano-Montalvo C., Meléndez L.M. Cystatin B associates with signal transducer and activator of transcription 1 in monocyte-derived and placental macrophages. Placenta 2009, 30:464-467.
43. Weil B.R., Manukyan M.C., Herrmann J.L., Wang Y., Abarbanell A.M., Poynter J.A., Meldrum D.R. Mesenchymal stem cells attenuate myocardial functional depression and reduce systemic and myocardial inflammation during endotoxemia. Surgery 2010, 148:444-452.
44. Németh K., Leelahavanichkul A., Yuen P.S., Mayer B., Parmelee A., Doi K., Robey P.G., Leelahavanichkul K., Koller B.H., Brown J.M., Hu X., Jelinek I., Star R.A., Mezey E. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 2009, 15:42-49.